Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 3 | 11 | 596 | 1 | 11 | 0.14 | 198.67 | ||
2 | Report on carcinogens. Monograph on .. | book series | 0.111 | 2 | 4 | 5 | 716 | 1 | 5 | 0.00 | 179.00 | |
3 | Drug Resistance Updates | journal | 3.794 Q1 | 132 | 31 | 41 | 5374 | 454 | 41 | 12.10 | 173.35 | |
4 | Advances in Cancer Research | journal | 2.389 Q1 | 109 | 31 | 111 | 4808 | 688 | 0 | 6.23 | 155.10 | |
5 | European Journal of Cancer, Supplement | journal | 0.942 Q2 | 29 | 1 | 86 | 146 | 102 | 71 | 2.43 | 146.00 | |
6 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 3.830 Q1 | 159 | 57 | 176 | 7804 | 1675 | 176 | 10.15 | 136.91 | |
7 | Journal of Carcinogenesis | journal | 1.227 Q2 | 43 | 2 | 40 | 266 | 156 | 40 | 3.78 | 133.00 | |
8 | Blood Reviews | journal | 2.501 Q1 | 112 | 48 | 108 | 5806 | 784 | 107 | 6.62 | 120.96 | |
9 | Cancer and Metastasis Reviews | journal | 2.605 Q1 | 167 | 44 | 182 | 5172 | 1089 | 175 | 4.85 | 117.55 | |
10 | Translational Oncogenomics | journal | 1.093 Q2 | 11 | 2 | 6 | 219 | 28 | 6 | 4.67 | 109.50 | |
11 | Critical Reviews in Oncology/Hematology | journal | 1.988 Q1 | 144 | 252 | 373 | 23710 | 2077 | 373 | 5.37 | 94.09 | |
12 | Current Cancer Drug Targets | journal | 1.271 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | |
13 | Nature Reviews Cancer | journal | 22.315 Q1 | 505 | 107 | 442 | 9738 | 8283 | 205 | 16.77 | 91.01 | |
14 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q2 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 | |
15 | Recent Results in Cancer Research | book series | 0.601 Q3 | 63 | 55 | 195 | 4879 | 413 | 172 | 2.28 | 88.71 | |
16 | Hematologic Malignancies | book series | 0.145 Q4 | 3 | 15 | 26 | 1326 | 2 | 23 | 0.08 | 88.40 | |
17 | Hepatic Oncology | journal | 3 | 3 | 0 | 264 | 0 | 0 | 0.00 | 88.00 | ||
18 | Ca-A Cancer Journal for Clinicians | journal | 43.002 Q1 | 211 | 42 | 118 | 3503 | 10225 | 109 | 101.16 | 83.40 | |
19 | Cancers | journal | 1.906 Q1 | 133 | 109 | 343 | 9010 | 1854 | 339 | 5.63 | 82.66 | |
20 | Cancer Treatment Reviews | journal | 3.146 Q1 | 164 | 110 | 336 | 8858 | 3096 | 336 | 9.86 | 80.53 | |
21 | Melanoma Management | journal | 0.282 Q3 | 14 | 3 | 13 | 224 | 6 | 13 | 0.46 | 74.67 | |
22 | Cancer Treatment and Research | journal | 1.056 Q2 | 65 | 65 | 131 | 4811 | 469 | 125 | 3.77 | 74.02 | |
23 | Cancer Biology and Medicine | journal | 1.427 Q1 | 62 | 51 | 114 | 3661 | 516 | 113 | 5.34 | 71.78 | |
24 | Molecular Cancer | journal | 2.439 Q1 | 196 | 75 | 630 | 5354 | 4254 | 626 | 6.50 | 71.39 | |
25 | World Journal of Clinical Oncology (discontinued) | journal | 1.467 Q1 | 48 | 48 | 154 | 3388 | 658 | 154 | 4.27 | 70.58 | |
26 | Oncology Reviews | journal | 0.474 Q3 | 31 | 8 | 28 | 545 | 44 | 28 | 1.75 | 68.13 | |
27 | American Journal of Blood Research | journal | 0.220 Q3 | 6 | 1 | 7 | 68 | 7 | 7 | 1.00 | 68.00 | |
28 | Current Problems in Cancer | journal | 0.353 Q3 | 47 | 20 | 83 | 1357 | 82 | 68 | 1.09 | 67.85 | |
29 | Current Oncology Reports | journal | 0.915 Q2 | 77 | 73 | 204 | 4950 | 574 | 191 | 3.01 | 67.81 | |
30 | Endocrine-Related Cancer | journal | 2.155 Q1 | 146 | 149 | 379 | 10103 | 2083 | 353 | 5.43 | 67.81 | |
31 | Lung Cancer International | journal | 0.123 Q4 | 3 | 1 | 1 | 67 | 1 | 1 | 1.00 | 67.00 | |
32 | Current Breast Cancer Reports | journal | 0.377 Q3 | 24 | 31 | 101 | 2072 | 79 | 100 | 0.56 | 66.84 | |
33 | Cancer Nanotechnology | journal | 0.875 Q2 | 36 | 11 | 26 | 733 | 118 | 26 | 5.64 | 66.64 | |
34 | Current Hematologic Malignancy Reports | journal | 1.116 Q2 | 44 | 63 | 149 | 4124 | 379 | 149 | 2.39 | 65.46 | |
35 | Expert Review of Anticancer Therapy | journal | 0.760 Q2 | 85 | 144 | 443 | 9425 | 861 | 423 | 2.08 | 65.45 | |
36 | International Journal of Cancer Research and Prevention | journal | 0.105 Q4 | 5 | 26 | 72 | 1696 | 5 | 72 | 0.08 | 65.23 | |
37 | Seminars in Oncology | journal | 2.127 Q1 | 145 | 96 | 295 | 6224 | 1487 | 260 | 5.69 | 64.83 | |
38 | Trends in Cancer | journal | 2.945 Q1 | 90 | 93 | 34 | 5983 | 105 | 25 | 3.09 | 64.33 | |
39 | World Journal of Gastrointestinal Oncology | journal | 42 | 81 | 93 | 5169 | 365 | 93 | 3.92 | 63.81 | ||
40 | Current Treatment Options in Oncology | journal | 1.208 Q2 | 66 | 65 | 160 | 4113 | 507 | 160 | 3.38 | 63.28 | |
41 | Frontiers in Oncology | journal | 2.042 Q1 | 136 | 277 | 1003 | 17461 | 4751 | 926 | 4.95 | 63.04 | |
42 | Seminars in Radiation Oncology | journal | 2.096 Q1 | 103 | 44 | 121 | 2771 | 601 | 108 | 5.26 | 62.98 | |
43 | Immunotherapy | journal | 0.829 Q2 | 65 | 135 | 385 | 8438 | 795 | 343 | 2.42 | 62.50 | |
44 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 5 | 1 | 311 | 0 | 1 | 0.00 | 62.20 | ||
45 | Cellular oncology (Dordrecht) | journal | 1.199 Q2 | 58 | 49 | 131 | 2999 | 521 | 130 | 4.35 | 61.20 | |
46 | Clinical Medicine Insights: Oncology | journal | 0.922 Q2 | 33 | 25 | 62 | 1529 | 173 | 61 | 3.05 | 61.16 | |
47 | Current Opinion in HIV and AIDS | journal | 2.354 Q1 | 78 | 91 | 241 | 5483 | 993 | 226 | 4.11 | 60.25 | |
48 | Cardio-Oncology | journal | 21 | 9 | 6 | 542 | 3 | 5 | 0.50 | 60.22 | ||
49 | Therapeutic Advances in Medical Oncology | journal | 2.259 Q1 | 68 | 38 | 80 | 2260 | 496 | 75 | 7.28 | 59.47 | |
50 | Biologics: Targets and Therapy | journal | 1.133 Q2 | 47 | 18 | 65 | 1047 | 276 | 63 | 3.76 | 58.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®